High Intensity Focused Ultrasound Market Size & Outlook, 2026-2034

High Intensity Focused Ultrasound Market Overview

The global high intensity focused ultrasound market size is valued at USD 1.40 billion in 2025 and is estimated to reach USD 2.61 billion by 2034, growing at a CAGR of 7.12% during the forecast period. The accelerated growth of the market is supported by the rising integration of AI-optimized targeting algorithms that increase precision and expand HIFU effectiveness.

Key Market Trends & Insights

• North America dominated the global market, accounting for a 31.21% share in 2025.
• The Asia Pacific region is projected to grow at the fastest pace, with a CAGR of 41%.
• Based on the method, the non-invasive segment dominated the market with a revenue share of 41.39% in 2025.
• By application, the dermatology segment dominated the market with a revenue share of
• Based on end use, the hospitals segment dominated the market in 2025 with a revenue share of 43.65%.
• The U.S. dominates the high intensity focused ultrasound market, valued at USD 371.43 million in 2024 and reaching USD 396.28 million in 2025.

Table: U.S. High Intensity Focused Ultrasound Market Size (USD Million)

Source: Straits Research

Market Size & Forecast

• 2025 Market Size: USD 1.40 billion
• 2034 Projected Market Size: USD 2.61 billion
• CAGR (2026-2034): 7.12%
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

The global high intensity focused ultrasound market comprises a diverse range of therapeutic methods, including non-invasive and minimally invasive techniques designed to deliver precise, targeted energy for tissue ablation and neuromodulation. HIFU is widely applied across multiple clinical areas such as uterine fibroids, prostate cancer, essential tremor, dermatology, breast cancer, glaucoma, and other indications. These procedures are performed across hospitals, imaging centers, and other healthcare facilities, supporting broad clinical adoption and expanding patient access to advanced non-surgical treatment options.

Latest Market Trends

Integration of MRI-guided and AI-enhanced precision Systems

A major trend in the high intensity focused ultrasound market is the rapid integration of MRI-guided and AI-enhanced targeting systems to improve treatment precision and safety. Advanced imaging guidance allows clinicians to visualize tissue structures in real time, enabling more accurate energy delivery and reducing the risk of collateral damage. The incorporation of AI algorithms further enhances treatment planning, automates workflow steps, and optimizes patient-specific therapy outcomes. This technological shift is accelerating clinical adoption and expanding the therapeutic potential of HIFU across multiple indications.

Growing Adoption of HIFU-based Combination Therapies

The high intensity focused ultrasound market is a growing establishment of dedicated non-invasive therapy centers within hospitals and private specialty clinics. These focused ultrasound units are expanding rapidly as healthcare providers seek to offer outpatient, incision-free treatment alternatives for conditions such as uterine fibroids, prostate cancer, and essential tremor. The development of these specialized centers increases procedure availability, reduces patient wait times, and accelerates the adoption of advanced HIFU technologies, driving broader clinical acceptance worldwide.

To get more insights about this report Download Free Sample Report

Market Driver

Expanding Adoption of Non-invasive Oncology Treatments

The increasing demand for non-invasive cancer treatment options is a major driver of the market. As cancer incidence rises globally, patients and clinicians are seeking alternatives to traditional surgery and radiation. For instance, various cancer centers in the U.S. and Europe have recently integrated HIFU systems to treat localized prostate and liver tumors, offering faster recovery and reduced complications.

This shift toward incision-free oncology solutions is boosting HIFU adoption and accelerating market growth.

Market Restraints

High Equipment and Operational Costs

The substantial cost of high intensity focused ultrasound systems and associated operational expenses remain a key restraint for market growth. For example, MRI-guided HIFU platforms such as Insightec’s Exablate cost upwards of USD 1 million, excluding maintenance and specialized staff training. Many hospitals in emerging economies face budget constraints, limiting adoption.

These high capital requirements, combined with limited reimbursement in several regions, restrict accessibility and slow the widespread integration of HIFU technologies.

Market Opportunity

Expansion of HIFU Adoption In Emerging Healthcare Markets

Growing investment in healthcare infrastructure and increasing awareness of non-invasive treatment options in emerging economies present notable opportunities for market growth. For instance, hospitals in India and Brazil are increasingly integrating HIFU systems for treating prostate cancer and uterine fibroids as part of public health initiatives and private specialty centers. This broader accessibility allows manufacturers to tap into large, underserved patient populations, driving market growth and regional adoption of advanced HIFU technologies.

Regional Analysis

North America dominated the high intensity focused ultrasound market in 2025, accounting for 31.21% market share. This growth is augmented by strong presence of leading HIFU manufacturers and research institutions, in drives market growth by fostering innovation, facilitating clinical trials, and ensuring early adoption of advanced focused ultrasound technologies.

U.S. high intensity focused ultrasound market growth is driven by substantial government and private funding for clinical research, which accelerates the development and adoption of innovative HIFU technologies. This support enables advanced clinical trials, technology refinement, and wider integration of HIFU in hospitals and specialty centers.

Asia Pacific Market Insights

Asia Pacific is emerging as the fastest-growing region with a CAGR of 8.41% from 2026 to 2034, owing to the rapid expansion of private healthcare facilities and increased government initiatives promoting advanced non-invasive treatments. This is enhancing patient access to HIFU therapies across oncology, gynecology, and neurology.

Australia high intensity focused ultrasound market growth is supported by increasing investments in advanced medical technologies and growing adoption of outpatient non-invasive procedures. The presence of well-equipped private clinics and research institutions enables wider access to HIFU treatments, driving market expansion across oncology and women’s health applications.

Regional Market share (%) in 2025

Source: Straits Research

Europe High Market Insights

Europe high intensity focused ultrasound market is boosted by the rising geriatric population and the increasing prevalence of chronic conditions such as prostate cancer and uterine fibroids. Growing patient demand for non-invasive, precise treatment options encourages healthcare providers to adopt HIFU technologies, supporting regional market expansion.

In UK, the high intensity focused ultrasound market is experiencing notable growth, driven by increasing adoption of private healthcare services and specialized outpatient clinics. These facilities offer advanced HIFU treatments with shorter waiting times, improving patient access and encouraging wider acceptance of non-invasive therapeutic procedures.

Latin America Market Insights

Latin America’s high intensity focused ultrasound market is being driven by rising adoption of medical tourism, where patients seek advanced non-invasive treatments at competitive costs. Countries like Brazil and Mexico are increasingly offering HIFU therapies, attracting both domestic and international patients, thereby boosting market growth.

The growth of Brazil high intensity focused ultrasound market is driven by growing awareness and demand for minimally invasive cosmetic and dermatology procedures. Clinics in major cities are increasingly offering HIFU-based skin tightening, fat reduction, and scar treatment services, attracting a growing patient base and contributing to market expansion.

Middle East and Africa Market Insights

The Middle East and Africa high intensity focused ultrasound market growth is stimulated by the increasing prevalence of lifestyle-related diseases, including prostate and breast cancer. Growing patient demand for non-invasive, precise treatment options encourages hospitals and clinics to adopt HIFU technologies, supporting regional market expansion.

South Africa high-intensity focused ultrasound market growth is supported by increasing collaboration between local hospitals and international HIFU technology providers. These partnerships facilitate technology transfer, clinician training, and pilot programs, enabling early adoption of advanced non-invasive therapies for oncology and gynecology, and creating a niche growth pathway.

Method Insights

The non-invasive segment dominated the market in 2025, owing to its ability to minimize surgical risks and reduce hospital stay durations. Patients increasingly prefer procedures that offer effective treatment with faster recovery, driving demand for non-invasive HIFU therapies across multiple indications.

The minimally invasive segment is estimated to register the fastest CAGR of 8.91% during the forecast period, due to advancements in precision-guided HIFU instruments that enable targeted tissue ablation with minimal trauma, improving procedural efficiency and patient comfort across diverse clinical applications.

Application Insights

The dermatology segment dominated the market in 2025, accounting for 21.42% revenue share. This growth is driven by rising demand for non-invasive cosmetic procedures, including skin tightening, scar reduction, and fat reduction, where HIFU offers effective results with minimal downtime.

The prostate cancer segment is estimated to register the fastest CAGR of 8.28% during the forecast period. This growth is attributed to rising preference for outpatient, organ-preserving treatments, with HIFU offering precise tumor targeting while minimizing complications and preserving urinary and sexual functions.

By Application Market Share (%), 2025

Source: Straits Research

End Use Insights

The hospitals segment dominated the market with the highest revenue share of 43.65% in 2025. This growth is supported by hospitals’ ability to offer multi-disciplinary HIFU services, combining advanced imaging, skilled specialists, and comprehensive post-procedure care, ensuring higher treatment adoption.

The imaging centers segment is projected to register the fastest CAGR from 2026-2034, due to the increasing availability of dedicated outpatient HIFU units equipped with advanced ultrasound and MRI imaging, enabling high precision, efficient treatments in specialized settings.

Competitive Landscape

The global high intensity focused ultrasound market is moderately consolidated, with a mix of established medical device manufacturers and emerging innovators shaping the competitive landscape. Leading players such as Insightec Ltd., EDAP TMS S.A., Chongqing Haifu Medical Technology, and HistoSonics maintain strong market positions through technological advancements, regulatory approvals, and expanding clinical applications. Continuous R&D investment, strategic partnerships, and growing adoption of non-invasive therapies further enhance competition across key therapeutic segments.

HistoSonics: An emerging market player

HistoSonics is rapidly emerging in the high intensity focused ultrasound market with its novel histotripsy technology, a non-thermal, non-invasive therapeutic approach that mechanically destroys targeted tissues with high precision. The company gained strong investor confidence, supported by substantial funding rounds and expanding clinical trials across liver and kidney tumor applications.

• In 2024, HistoSonics advanced its Edison system into broader commercial rollout following favorable clinical results and regulatory progress. Thus, HistoSonics is positioning itself as a transformative emerging player in the HIFU landscape.

List of key players in High Intensity Focused Ultrasound Market

1. Alpinion Medical Systems
2. AMI Technologies Ltd.
3. Arrayus Technologies Inc.
4. Bracco
5. Chongqing Haifu Medical Technology
6. Chengji Electronic Technology
7. EDAP TMS S.A.
8. Elekta
9. GE HealthCare
10. HistoSonics
11. Hitachi, Ltd.
12. Insightec Ltd.
13. Koninklijke Philips N.V.
14. Profound Medical
15. Shenzhen Promethe Medical Sci-Tech Co.
16. Theraclion S.A.
17. Advanced Microbubbles, Inc.
18. Others

To get more findings about this report Download Market Share

Strategic Initiatives

• January 2024: Kokilaben Dhirubhai Ambani Hospital launched the revolutionary High Intensity Focused Ultrasound (HIFU) technology for patients with prostate cancer.